Literature DB >> 15592802

[Compression syndromes].

J Wierecky1, C Bokemeyer.   

Abstract

Superior vena cava syndrome is a medical condition determined by the mechanisms of extrinsic compression, invasion or thrombosis of the superior vena cava. The most common underlying cause is a malignant process, especially lung cancer and lymphoma. Typical symptoms include progressive dyspnea, head and upper body edema and cyanosis. Most patients can be treated with appropriately directed chemotherapy or radiotherapy. Accurate diagnosis of the underlying etiology needs to be established before treatment. Only under extreme emergency conditions such as laryngeal or cerebral edema irradiation should be initiated without a histological diagnosis. With the refinement of endovascular stents, percutaneous stenting is being increasingly used as primary treatment modality. Metastatic spinal cord compression is one of the most dreadful complications of cancer. In most patients the initial symptom is progressive back pain with an axial or radicular distribution. MRI should be preferred in the diagnostic work-up, corticosteroids be administered promptly after biopsy. Radiation therapy or surgical treatment should be started as soon as possible.

Entities:  

Mesh:

Year:  2005        PMID: 15592802     DOI: 10.1007/s00108-004-1318-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  25 in total

1.  Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy.

Authors:  A A Nicholson; D F Ettles; A Arnold; M Greenstone; J F Dyet
Journal:  J Vasc Interv Radiol       Date:  1997 Sep-Oct       Impact factor: 3.464

Review 2.  Spinal cord compression from epidural metastases.

Authors:  T N Byrne
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

Review 3.  Superior vena cava obstruction: a modern management strategy.

Authors:  P J Ostler; D P Clarke; A F Watkinson; M N Gaze
Journal:  Clin Oncol (R Coll Radiol)       Date:  1997       Impact factor: 4.126

4.  Position of the American Academy of Neurology on certain aspects of the care and management of the persistent vegetative state patient. Adopted by the Executive Board, American Academy of Neurology, April 21, 1988, Cincinnati, Ohio.

Authors: 
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

5.  The use of the Wallstent endovascular prosthesis in the treatment of malignant obstruction of the superior vena cava.

Authors:  J F Dyet; A A Nicholson; A M Cook
Journal:  Clin Radiol       Date:  1993-12       Impact factor: 2.350

6.  Metastatic spinal cord compression: radiotherapy outcome and dose fractionation.

Authors:  Peter J Hoskin; Amit Grover; Rajanee Bhana
Journal:  Radiother Oncol       Date:  2003-08       Impact factor: 6.280

7.  Role of mediastinoscopy in superior vena cava obstruction.

Authors:  M Jahangiri; D P Taggart; P Goldstraw
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

8.  Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients.

Authors:  S Helweg-Larsen; P S Sørensen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  Epidural spinal cord compression from metastatic tumor: diagnosis and treatment.

Authors:  R W Gilbert; J H Kim; J B Posner
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

10.  Thromboembolic events in patients with malignant superior vena cava syndrome and the role of anticoagulation.

Authors:  D J Adelstein; J D Hines; S G Carter; D Sacco
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

View more
  1 in total

1.  Pulmonary hilar lymph node metastasis of breast cancer induced bronchopleural fistula and superior vena cava syndrome.

Authors:  Yutaka Nishinari; Masahiro Kashiwaba; Akira Umemura; Hideaki Komatsu; Akira Sasaki; Go Wakabayashi
Journal:  Am J Case Rep       Date:  2014-11-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.